Obsessive Compulsive Disorder Market Expected to Experience Major Growth by 2034, According to DelveInsight | Biohaven Pharmaceuticals, Inc., AbbVie, Biohaven Pharmaceuticals, Inc., AstraZeneca, MedtronicNeuro, Hoffmann-La Roche

DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the OCD market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder Market Forecast
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Obsessive Compulsive Disorder Market Report:
• The Obsessive Compulsive Disorder market size was valued approximately USD 11,00 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In January 2024, Troriluzole, a new glutamate modulator, is currently in Phase 3 development for treating obsessive-compulsive disorder (OCD). It is being tested as an additional therapy for patients who have not responded adequately to standard treatments. The Phase 2 trial of troriluzole in OCD showed consistent numerical improvements compared to placebo on the Yale-Brown Obsessive Compulsive Scale (the primary endpoint) at all timepoints, which helped shape the design of the Phase 3 study.
• In 2022, there were approximately 12,082,000 prevalent cases of OCD across the 7MM. It is anticipated that these numbers will rise by the year 2034.
• In the EU4 countries and the UK, Germany had the highest number of OCD cases, approximately ~2,121,000 in 2022, with expectations of an increase by 2034.
• In 2022, Japan had approximately 2,150,000 prevalent cases of OCD, representing around 18% of the total OCD cases across the 7MM.
• In 2022, there were approximately 7,212,000 diagnosed cases of OCD across the 7MM. These cases are projected to rise by 2034.
• In the UK, around 100,000 cases of OCD were prevalent among males and approximately 356,000 cases among females in 2022. These numbers are anticipated to rise by 2034.
• In 2022, the lowest number of age-specific prevalent OCD cases were seen in individuals aged 60 and above, while the highest number of cases occurred in the 30-44 age group in France.
• Key Obsessive Compulsive Disorder Companies: iohaven Pharmaceuticals, Inc., AbbVie, Biohaven Pharmaceuticals, Inc., AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Ortho-McNeil Janssen Scientific, Pfizer, and others
• Key Obsessive Compulsive Disorder Therapies: Troriluzole, Fluvoxamine maleate, BHV-4157, Troriluzole, Quetiapine, Reclaim®, Bitopertin, topiramate, Escitalopram, Duloxetine, Topiramate, Paliperidone, pregabalin, and others
• The Obsessive Compulsive Disorder epidemiology based on gender analyzed that the occurrence of gender-specific cases of OCD is more in females than in males
• The Obsessive Compulsive Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Obsessive Compulsive Disorder pipeline products will significantly revolutionize the Obsessive Compulsive Disorder market dynamics.

Obsessive Compulsive Disorder Overview
Obsessive-Compulsive Disorder (OCD) is a mental health condition characterized by persistent, unwanted thoughts (obsessions) and repetitive behaviors or mental acts (compulsions). People with OCD often feel compelled to perform certain rituals or routines in an attempt to reduce the anxiety caused by their obsessions, even though these actions may offer only temporary relief and may not be logically connected to the obsession.

Get a Free sample for the Obsessive Compulsive Disorder Market Report -
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Obsessive Compulsive Disorder Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Obsessive Compulsive Disorder Epidemiology Segmentation:
The Obsessive Compulsive Disorder market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Obsessive Compulsive Disorder
• Prevalent Cases of Obsessive Compulsive Disorder by severity
• Gender-specific Prevalence of Obsessive Compulsive Disorder
• Diagnosed Cases of Episodic and Chronic Obsessive Compulsive Disorder

Download the report to understand which factors are driving Obsessive Compulsive Disorder epidemiology trends @ Obsessive Compulsive Disorder Epidemiology Forecast
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Obsessive Compulsive Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Obsessive Compulsive Disorder market or expected to get launched during the study period. The analysis covers Obsessive Compulsive Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Obsessive Compulsive Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Obsessive Compulsive Disorder Therapies and Key Companies
• Troriluzole: Biohaven Pharmaceuticals, Inc.
• Fluvoxamine maleate: AbbVie
• BHV-4157: Biohaven Pharmaceuticals, Inc.
• Quetiapine: AstraZeneca
• Reclaim®: MedtronicNeuro
• Bitopertin: Hoffmann-La Roche
• topiramate: Ortho-McNeil Pharmaceutical
• Escitalopram: Forest Laboratories
• Duloxetine: Eli Lilly and Company
• Topiramate: Janssen-Ortho Inc
• Paliperidone: Ortho-McNeil Janssen Scientific
• pregabalin: Pfizer

Discover more about therapies set to grab major Obsessive Compulsive Disorder market share @ Obsessive Compulsive Disorder Treatment Market
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Obsessive Compulsive Disorder Market Drivers
• Negative lifestyle practices like unhealthy eating habits,smoking, lack of abundant sleep, and sedentary routine further proliferate anxiety disorders among individuals.
• Even though the emerging pipeline for OCD is not robust, the expected approval of troriluzole, a late-stage drug candidate with novel MoA, would drive the market.

Obsessive Compulsive Disorder Market Barriers
• SRIs, antipsychotics, mood stabilizers, and CBT are the mainstay of treatment for OCD. Therapies with novel MoAs are required to exhibit better efficacy and fewer side effects.
• Although several clinical, environmental, and biological predictors of response have been reported, delivering more personalized treatments for OCD is not a reality thus far.

Scope of the Obsessive Compulsive Disorder Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Obsessive Compulsive Disorder Companies: iohaven Pharmaceuticals, Inc., AbbVie, Biohaven Pharmaceuticals, Inc., AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Ortho-McNeil Janssen Scientific, Pfizer, and others
• Key Obsessive Compulsive Disorder Therapies: Troriluzole, Fluvoxamine maleate, BHV-4157, Troriluzole, Quetiapine, Reclaim®, Bitopertin, topiramate, Escitalopram, Duloxetine, Topiramate, Paliperidone, pregabalin, and others
• Obsessive Compulsive Disorder Therapeutic Assessment: Obsessive Compulsive Disorder current marketed and Obsessive Compulsive Disorder emerging therapies
• Obsessive Compulsive Disorder Market Dynamics: Obsessive Compulsive Disorder market drivers and Obsessive Compulsive Disorder market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Obsessive Compulsive Disorder Unmet Needs, KOL's views, Analyst's views, Obsessive Compulsive Disorder Market Access and Reimbursement

To know more about Obsessive Compulsive Disorder companies working in the treatment market, visit @ Obsessive Compulsive Disorder Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Obsessive Compulsive Disorder Market Report Introduction
2. Executive Summary for Obsessive Compulsive Disorder
3. SWOT analysis of Obsessive Compulsive Disorder
4. Obsessive Compulsive Disorder Patient Share (%) Overview at a Glance
5. Obsessive Compulsive Disorder Market Overview at a Glance
6. Obsessive Compulsive Disorder Disease Background and Overview
7. Obsessive Compulsive Disorder Epidemiology and Patient Population
8. Country-Specific Patient Population of Obsessive Compulsive Disorder
9. Obsessive Compulsive Disorder Current Treatment and Medical Practices
10. Obsessive Compulsive Disorder Unmet Needs
11. Obsessive Compulsive Disorder Emerging Therapies
12. Obsessive Compulsive Disorder Market Outlook
13. Country-Wise Obsessive Compulsive Disorder Market Analysis (2020-2034)
14. Obsessive Compulsive Disorder Market Access and Reimbursement of Therapies
15. Obsessive Compulsive Disorder Market Drivers
16. Obsessive Compulsive Disorder Market Barriers
17. Obsessive Compulsive Disorder Appendix
18. Obsessive Compulsive Disorder Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Obsessive Compulsive Disorder Pipeline https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Obsessive Compulsive Disorder Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Obsessive Compulsive Disorder market. A detailed picture of the Obsessive Compulsive Disorder pipeline landscape is provided, which includes the disease overview and Obsessive Compulsive Disorder treatment guidelines.

Obsessive Compulsive Disorder Epidemiology https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Obsessive Compulsive Disorder Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Obsessive Compulsive Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market
DelveInsight's "Idiopathic Thrombocytopenic Purpura Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Idiopathic Thrombocytopenic Purpura, historical and forecasted epidemiology as well as the Idiopathic Thrombocytopenic Purpura market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Inguinal Hernia Market
https://www.delveinsight.com/report-store/inguinal-hernia-market
DelveInsight's "Inguinal Hernia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Inguinal Hernia, historical and forecasted epidemiology as well as the Inguinal Hernia market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Charcot-marie-tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market
DelveInsight's 'Charcot-Marie-Tooth Disease Market Insights, Epidemiology, and Market Forecast 2032' report deliver an in-depth understanding of the Charcot-Marie-Tooth Disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.

Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
DelveInsight's "Dysfunctional Uterine Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Dysfunctional Uterine Bleeding, historical and forecasted epidemiology as well as the Dysfunctional Uterine Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Mrna Based Vaccines And Therapeutics Market
https://www.delveinsight.com/report-store/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market
DelveInsight's "Global Messenger RNA (mRNA)-based Vaccines and Therapeutics- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Papilloma Market
https://www.delveinsight.com/report-store/papilloma-market
DelveInsight's "Papilloma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Papilloma, historical and forecasted epidemiology as well as the Papilloma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Periodontal Disease Market
https://www.delveinsight.com/report-store/periodontal-disease-market
DelveInsight's "Periodontal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Periodontal Disease, historical and forecasted epidemiology as well as the Periodontal Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.